These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38486026)

  • 41. miR-550a-3/NFIC plays a driving role in esophageal squamous cell cancer cells proliferation and metastasis partly through EMT process.
    Wang H; Shi X; Wu S
    Mol Cell Biochem; 2020 Sep; 472(1-2):115-123. PubMed ID: 32567032
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Integrating transcriptome and metabolome variability to reveal pathogenesis of esophageal squamous cell carcinoma.
    Cheng J; Liu Q; Jin H; Zeng D; Liao Y; Zhao Y; Gao X; Zheng G
    Biochim Biophys Acta Mol Basis Dis; 2021 Jan; 1867(1):165966. PubMed ID: 32931889
    [TBL] [Abstract][Full Text] [Related]  

  • 43. L1CAM drives oncogenicity in esophageal squamous cell carcinoma by stimulation of ezrin transcription.
    Guo JC; Xie YM; Ran LQ; Cao HH; Sun C; Wu JY; Wu ZY; Liao LD; Zhao WJ; Fang WK; Li EM; Xu LY; Schachner M; Xie JJ
    J Mol Med (Berl); 2017 Dec; 95(12):1355-1368. PubMed ID: 28939985
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
    Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
    J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Spatial heterogeneity and Immune infiltration of cellular lysosomal pathways reveals a new blueprint for tumor heterogeneity in esophageal cancer.
    Wei J; Wu X; Wang S; Liu S; Gao X
    Front Endocrinol (Lausanne); 2023; 14():1138457. PubMed ID: 37091857
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comprehensive analysis of mRNA expression profiles of Esophageal Squamous Cell Carcinoma reveals downregulation of Desmoglein 1 and crucial genomic targets.
    Alotaibi A; Gadekar VP; Gundla PS; Mandarthi S; Ravi S; Mallya D; Tungekar A; Lavanya BV; Bhagavath AK; Cordero MW; Pitkaniemi J; Seetharam RN; Bepari A; Hebbar P
    Cancer Biomark; 2023; 38(4):465-487. PubMed ID: 38073377
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alterations in glucose metabolism proteins responsible for the Warburg effect in esophageal squamous cell carcinoma.
    de Andrade Barreto E; de Souza Santos PT; Bergmann A; de Oliveira IM; Wernersbach Pinto L; Blanco T; Rossini A; Pinto Kruel CD; Mattos Albano R; Ribeiro Pinto LF
    Exp Mol Pathol; 2016 Aug; 101(1):66-73. PubMed ID: 27260309
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Roles of PTEN inactivation and PD-1/PD-L1 activation in esophageal squamous cell carcinoma.
    Qiu R; Wang W; Li J; Wang Y
    Mol Biol Rep; 2022 Jul; 49(7):6633-6645. PubMed ID: 35301651
    [TBL] [Abstract][Full Text] [Related]  

  • 49. SASS6 promotes proliferation of esophageal squamous carcinoma cells by inhibiting the p53 signaling pathway.
    Xu Y; Zhu K; Chen J; Lin L; Huang Z; Zhang J; Chen Y
    Carcinogenesis; 2021 Feb; 42(2):254-262. PubMed ID: 32671379
    [TBL] [Abstract][Full Text] [Related]  

  • 50. EPB41L5 promotes EMT through the ERK/p38 MAPK signaling pathway in esophageal squamous cell carcinoma.
    Bao S; Ji Z; Shi M; Liu X
    Pathol Res Pract; 2021 Dec; 228():153682. PubMed ID: 34784520
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CCT4 knockdown enhances the sensitivity of cisplatin by inhibiting glycolysis in human esophageal squamous cell carcinomas.
    Fang J; Ma Y; Li Y; Li J; Zhang X; Han X; Ma S; Guan F
    Mol Carcinog; 2022 Nov; 61(11):1043-1055. PubMed ID: 36102200
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Low expression of PRDM5 predicts poor prognosis of esophageal squamous cell carcinoma.
    Guo J; Yang Q; Wei S; Shao J; Zhao T; Guo L; Liu J; Chen J; Wang G
    BMC Cancer; 2022 Jul; 22(1):745. PubMed ID: 35799142
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A novel and robust pyroptosis-related prognostic signature predicts prognosis and response to immunotherapy in esophageal squamous cell carcinoma.
    Zhang D; Zhao F; Li J; Qin X; Li S; Niu R
    Aging (Albany NY); 2023 Aug; 15(15):7811-7830. PubMed ID: 37561524
    [TBL] [Abstract][Full Text] [Related]  

  • 54. NRF2/ACSS2 axis mediates the metabolic effect of alcohol drinking on esophageal squamous cell carcinoma.
    Odera JO; Xiong Z; Huang C; Gu N; Yang W; Githang'a J; Odera E; Paiboonrungruang C; Chen X
    Biochem J; 2020 Aug; 477(16):3075-3089. PubMed ID: 32776152
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Outcomes of Radiation-Associated Esophageal Squamous Cell Carcinoma: The MSKCC Experience.
    Nobel TB; Barbetta A; Hsu M; Tan KS; Pinchinat T; Schlottmann F; Bains MS; Ku GY; Wu AJ; Patti MG; Jones DR; Molena D
    J Gastrointest Surg; 2019 Jan; 23(1):11-22. PubMed ID: 30215197
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aberrant methylation-mediated silencing of lncRNA CTC-276P9.1 is associated with malignant progression of esophageal squamous cell carcinoma.
    Guo W; Liu S; Dong Z; Guo Y; Ding C; Shen S; Liang J; Shan B
    Clin Exp Metastasis; 2018 Feb; 35(1-2):53-68. PubMed ID: 29524086
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic significance of tumor-infiltrating immune cells and PD-L1 expression in esophageal squamous cell carcinoma.
    Jiang Y; Lo AWI; Wong A; Chen W; Wang Y; Lin L; Xu J
    Oncotarget; 2017 May; 8(18):30175-30189. PubMed ID: 28404915
    [TBL] [Abstract][Full Text] [Related]  

  • 58. AKAP12 inhibits esophageal squamous carcinoma cell proliferation, migration, and cell cycle via the PI3K/AKT signaling pathway.
    Li X; Dong H; Zheng Y; Ding S; Li Y; Li H; Huang H; Zhong C; Xie T; Xu Y
    Mol Cell Probes; 2023 Dec; 72():101939. PubMed ID: 37879503
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The PSMD14 inhibitor Thiolutin as a novel therapeutic approach for esophageal squamous cell carcinoma through facilitating SNAIL degradation.
    Jing C; Li X; Zhou M; Zhang S; Lai Q; Liu D; Ye B; Li L; Wu Y; Li H; Yue K; Chen P; Yao X; Wu Y; Duan Y; Wang X
    Theranostics; 2021; 11(12):5847-5862. PubMed ID: 33897885
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effects of miR-429 on cell migration and invasion by targeting Slug in esophageal squamous cell carcinoma.
    Zong M; Liu Y; Zhang K; J Y; Chen L
    Pathol Res Pract; 2019 Sep; 215(9):152526. PubMed ID: 31324391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.